Regulations.gov document
Guidance for Industry on INDs for Phase 2 and Phase 3 Studies; Chemistry, Manufacturing…
Notice · FDA-1999-D-0030 · posted Jun 3, 2003
Key facts
| Document ID | FDA-1999-D-0030-0001 |
|---|---|
| Title | Guidance for Industry on INDs for Phase 2 and Phase 3 Studies; Chemistry, Manufacturing, and Controls Information; Availability |
| Document type | Notice |
| Subtype | Notice of Data Availability |
| Agency | FDA |
| Docket | FDA-1999-D-0030 |
| Posted | Jun 3, 2003 |
| Federal Register citation | 68 FR 27567 |
| FR document number | 03-12545 |
| Comment period opens | May 19, 2003 |
| Comments due | May 21, 2004 |
| Effective date | May 13, 2003 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: